NAOMI MUHIA: Open Payments
NPI 1831331297 · ACWORTH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 19 payments from 6 companies in 2025. Trend: 2023 $701 · 2024 $523 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $183 |
| Mallinckrodt Hospital Products Inc. | 4 | $78 |
| ABBVIE INC. | 4 | $69 |
| UCB, Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
Products named: XIFAXAN, TERLIVAZ, DALVANCE, TEFLARO, Briviact, GVOKE HYPOPEN.
Industry payments across GA — which companies pay providers there.
